Management of Muscle-Invasive Bladder Cancer During a Pandemic: Impact of Treatment Delay on Survival Outcomes for Patients Treated With Definitive Concurrent Chemoradiotherapy

Author:

Fischer-Valuck Benjamin W.,Michalski Jeff M.,Harton Joanna G.,Birtle Alison,Christodouleas John P.,Efstathiou Jason A.,Arora Vivek K.,Kim Eric H.,Knoche Eric M.,Pachynski Russell K.,Picus Joel,Rao Yuan James,Reimers Melissa,Roth Bruce J.,Sargos Paul,Smith Zachary L.,Zaghloul Mohamed S.,Gay Hiram A.,Patel Sagar A.,Baumann Brian C.

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference13 articles.

1. Prostate cancer radiotherapy recommendations in response to COVID-19;Zaorsky;Adv Radiat Oncol,2020

2. Breast radiotherapy under COVID-19 pandemic resource constraints—approaches to defer or shorten treatment from a comprehensive cancer center in the United States;Braunstein;Adv Radiat Oncol,2020

3. Epidemiological and clinical features of 125 hospitalized patients with COVID-19 in Fuyang, Anhui, China;Wang;Int J Infect Dis,2020

4. A retrospective analysis of the effect on survival of time from diagnosis to neoadjuvant chemotherapy to cystectomy for muscle invasive bladder cancer;Park;J Urol,2016

Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Squamous Cell Carcinoma of Bladder;Clinical Diagnosis and Management of Squamous Cell Carcinoma;2023-01-04

2. Outcomes by time to definitive chemoradiation treatment for patients with muscle-invasive bladder cancer;Urologic Oncology: Seminars and Original Investigations;2022-06

3. The impact of COVID 19 pandemic on urology literature: a bibliometric analysis;Central European Journal of Urology;2022

4. A Tailored Radiation Therapy Strategy for Older Patients With Localized Bladder Cancer Not Eligible for Curative Treatment;International Journal of Radiation Oncology*Biology*Physics;2021-06

5. The 2021 COVID-19 Artificial Intelligence Issue;Clinical Genitourinary Cancer;2021-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3